Histopathological Characterization and Development of Objective Diagnostic Criteria in Mycosis Fungoides

Background: Mycosis Fungoides is a subtype of Cutaneous T Cell Lymphomas, often difficult to diagnose in its early stages due to its histopathological resemblance to inflammatory dermatoses. Objectives: To refine and enhance the diagnostic criteria for Mycosis Fungoides by utilizing digital scanning and analysis systems for the quantitative evaluation of immunohistochemical markers. Methods: A retrospective longitudinal observational descriptive study based on the reevaluation and comparison of diagnostic criteria (histological and immunohistochemical) of patients with a clinical suspicion of MF, creating two groups: patients whose diagnosis, despite requiring numerous biopsies, was finally Mycosis Fungoides (MF Group), and patients who, despite clinical suspicion, always had a diagnosis of Inflammatory Dermatoses (Control Group). The study was conducted on 62 patients with clinical suspicion of MF who underwent punch biopsies between 2000 and 2022 at Severo Ochoa University Hospital. Histological and immunohistochemical markers (CD2, CD3, CD4, CD5, CD7, CD8, TOX) were assessed using APERIO AT2 LEICA BIOSYSTEMS scanner and CIVAGENIUS software, ensuring objective and reproducible results. Results: Basal epidermotropism, lymphocytic atypia, and peri-lymphocytic halo showed strong associations with MF diagnosis. Significant differences were observed in the CD3/CD8 and CD5/CD8 ratios between Mycosis Fungoides and Inflammatory Dermatoses groups. High TOX antibody expression correlated with early-stage MF diagnosis. These findings suggest the potential of combining marker ratios and TOX expression with digital analysis to improve diagnostic accuracy. Conclusions: Digital scanning and automated analysis systems significantly enhance the precision and efficiency of Mycosis Fungoides diagnosis. Implementing these methods in routine practice can reduce diagnostic delays and improve patient outcomes by differentiating Mycosis Fungoides from similar dermatological conditions more effectively.

Authors

Institutions

Publication Details

Journal
International Journal of Clinical and Experimental Medical Sciences
Published
2024-11-13
DOI
https://doi.org/10.11648/j.ijcems.20241004.12
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histopathological Characterization and Development of Objective Diagnostic Criteria in Mycosis Fungoides

Ignacio Pinilla-Pagnon, Montserrat Chao-Crecente, Rosa Rojo-López, Tania Sierra Hompanera et al.
International Journal of Clinical and Experimental Medical Sciences
Cutaneous lymphoproliferative disorders research
article

Histopathological Characterization and Development of Objective Diagnostic Criteria in Mycosis Fungoides

Ignacio Pinilla-Pagnon, Montserrat Chao-Crecente, Rosa Rojo-López, Tania Sierra Hompanera, Gonzalo Casasola
article en

Abstract

Background: Mycosis Fungoides is a subtype of Cutaneous T Cell Lymphomas, often difficult to diagnose in its early stages due to its histopathological resemblance to inflammatory dermatoses. Objectives: To refine and enhance the diagnostic criteria for Mycosis Fungoides by utilizing digital scanning and analysis systems for the quantitative evaluation of immunohistochemical markers. Methods: A retrospective longitudinal observational descriptive study based on the reevaluation and comparison of diagnostic criteria (histological and immunohistochemical) of patients with a clinical suspicion of MF, creating two groups: patients whose diagnosis, despite requiring numerous biopsies, was finally Mycosis Fungoides (MF Group), and patients who, despite clinical suspicion, always had a diagnosis of Inflammatory Dermatoses (Control Group). The study was conducted on 62 patients with clinical suspicion of MF who underwent punch biopsies between 2000 and 2022 at Severo Ochoa University Hospital. Histological and immunohistochemical markers (CD2, CD3, CD4, CD5, CD7, CD8, TOX) were assessed using APERIO AT2 LEICA BIOSYSTEMS scanner and CIVAGENIUS software, ensuring objective and reproducible results. Results: Basal epidermotropism, lymphocytic atypia, and peri-lymphocytic halo showed strong associations with MF diagnosis. Significant differences were observed in the CD3/CD8 and CD5/CD8 ratios between Mycosis Fungoides and Inflammatory Dermatoses groups. High TOX antibody expression correlated with early-stage MF diagnosis. These findings suggest the potential of combining marker ratios and TOX expression with digital analysis to improve diagnostic accuracy. Conclusions: Digital scanning and automated analysis systems significantly enhance the precision and efficiency of Mycosis Fungoides diagnosis. Implementing these methods in routine practice can reduce diagnostic delays and improve patient outcomes by differentiating Mycosis Fungoides from similar dermatological conditions more effectively.

International Journal of Clinical and Experimental Medical SciencesVol. 10(4)
Universidad Alfonso X el Sabio (ES), Hospital Universitario Severo Ochoa (ES)
Openalex Percentile: Top 56%
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.